nodes	percent_of_prediction	percent_of_DWPC	metapath
Pentoxifylline—NT5E—stomach cancer	0.755	1	CbGaD
Pentoxifylline—PDE5A—blood vessel—stomach cancer	0.00296	0.0688	CbGeAlD
Pentoxifylline—NT5E—hematopoietic system—stomach cancer	0.00243	0.0564	CbGeAlD
Pentoxifylline—NT5E—epithelium—stomach cancer	0.00222	0.0516	CbGeAlD
Pentoxifylline—NT5E—smooth muscle tissue—stomach cancer	0.00214	0.0497	CbGeAlD
Pentoxifylline—NT5E—pancreas—stomach cancer	0.00197	0.046	CbGeAlD
Pentoxifylline—ADORA2B—smooth muscle tissue—stomach cancer	0.00183	0.0426	CbGeAlD
Pentoxifylline—Caffeine—PIK3CA—stomach cancer	0.00176	1	CrCbGaD
Pentoxifylline—ADORA2A—hematopoietic system—stomach cancer	0.00173	0.0402	CbGeAlD
Pentoxifylline—NT5E—lymphoid tissue—stomach cancer	0.00171	0.0397	CbGeAlD
Pentoxifylline—PDE5A—hematopoietic system—stomach cancer	0.00157	0.0366	CbGeAlD
Pentoxifylline—NT5E—bone marrow—stomach cancer	0.00155	0.0362	CbGeAlD
Pentoxifylline—ADORA1—hematopoietic system—stomach cancer	0.00149	0.0347	CbGeAlD
Pentoxifylline—PDE5A—epithelium—stomach cancer	0.00144	0.0335	CbGeAlD
Pentoxifylline—NT5E—endocrine gland—stomach cancer	0.00139	0.0324	CbGeAlD
Pentoxifylline—PDE5A—smooth muscle tissue—stomach cancer	0.00139	0.0323	CbGeAlD
Pentoxifylline—NT5E—liver—stomach cancer	0.00126	0.0292	CbGeAlD
Pentoxifylline—ADORA2A—lymphoid tissue—stomach cancer	0.00122	0.0283	CbGeAlD
Pentoxifylline—PDE4B—hematopoietic system—stomach cancer	0.0011	0.0257	CbGeAlD
Pentoxifylline—PDE5A—digestive system—stomach cancer	0.00109	0.0255	CbGeAlD
Pentoxifylline—ADORA2A—endocrine gland—stomach cancer	0.000993	0.0231	CbGeAlD
Pentoxifylline—NT5E—lymph node—stomach cancer	0.000963	0.0224	CbGeAlD
Pentoxifylline—PDE5A—endocrine gland—stomach cancer	0.000904	0.021	CbGeAlD
Pentoxifylline—PDE4B—pancreas—stomach cancer	0.000899	0.0209	CbGeAlD
Pentoxifylline—ADORA2A—liver—stomach cancer	0.000895	0.0208	CbGeAlD
Pentoxifylline—ADORA1—endocrine gland—stomach cancer	0.000857	0.02	CbGeAlD
Pentoxifylline—PDE4B—lymphoid tissue—stomach cancer	0.000777	0.0181	CbGeAlD
Pentoxifylline—PDE4A—lymph node—stomach cancer	0.000735	0.0171	CbGeAlD
Pentoxifylline—PDE4B—bone marrow—stomach cancer	0.000708	0.0165	CbGeAlD
Pentoxifylline—CYP1A2—hematopoietic system—stomach cancer	0.000678	0.0158	CbGeAlD
Pentoxifylline—PDE4B—endocrine gland—stomach cancer	0.000634	0.0148	CbGeAlD
Pentoxifylline—PDE5A—lymph node—stomach cancer	0.000625	0.0145	CbGeAlD
Pentoxifylline—ADORA1—lymph node—stomach cancer	0.000593	0.0138	CbGeAlD
Pentoxifylline—PDE4B—liver—stomach cancer	0.000572	0.0133	CbGeAlD
Pentoxifylline—CYP1A2—digestive system—stomach cancer	0.000471	0.011	CbGeAlD
Pentoxifylline—PDE4B—lymph node—stomach cancer	0.000438	0.0102	CbGeAlD
Pentoxifylline—CYP1A2—endocrine gland—stomach cancer	0.00039	0.00907	CbGeAlD
Pentoxifylline—CYP1A2—liver—stomach cancer	0.000351	0.00817	CbGeAlD
Pentoxifylline—Discomfort—Capecitabine—stomach cancer	0.000131	0.00114	CcSEcCtD
Pentoxifylline—Epistaxis—Epirubicin—stomach cancer	0.000131	0.00114	CcSEcCtD
Pentoxifylline—Infection—Docetaxel—stomach cancer	0.00013	0.00113	CcSEcCtD
Pentoxifylline—Diarrhoea—Irinotecan—stomach cancer	0.00013	0.00113	CcSEcCtD
Pentoxifylline—Dry mouth—Capecitabine—stomach cancer	0.000129	0.00113	CcSEcCtD
Pentoxifylline—Shock—Docetaxel—stomach cancer	0.000129	0.00112	CcSEcCtD
Pentoxifylline—Pruritus—Fluorouracil—stomach cancer	0.000128	0.00112	CcSEcCtD
Pentoxifylline—Thrombocytopenia—Docetaxel—stomach cancer	0.000128	0.00112	CcSEcCtD
Pentoxifylline—Infestation—Doxorubicin—stomach cancer	0.000128	0.00112	CcSEcCtD
Pentoxifylline—Infestation NOS—Doxorubicin—stomach cancer	0.000128	0.00112	CcSEcCtD
Pentoxifylline—Drowsiness—Doxorubicin—stomach cancer	0.000128	0.00112	CcSEcCtD
Pentoxifylline—Confusional state—Capecitabine—stomach cancer	0.000128	0.00111	CcSEcCtD
Pentoxifylline—Tachycardia—Docetaxel—stomach cancer	0.000128	0.00111	CcSEcCtD
Pentoxifylline—Skin disorder—Docetaxel—stomach cancer	0.000127	0.00111	CcSEcCtD
Pentoxifylline—Oedema—Capecitabine—stomach cancer	0.000127	0.00111	CcSEcCtD
Pentoxifylline—Infection—Capecitabine—stomach cancer	0.000126	0.0011	CcSEcCtD
Pentoxifylline—Dizziness—Irinotecan—stomach cancer	0.000125	0.00109	CcSEcCtD
Pentoxifylline—Haemoglobin—Epirubicin—stomach cancer	0.000125	0.00109	CcSEcCtD
Pentoxifylline—Jaundice—Doxorubicin—stomach cancer	0.000125	0.00109	CcSEcCtD
Pentoxifylline—Anorexia—Docetaxel—stomach cancer	0.000125	0.00109	CcSEcCtD
Pentoxifylline—Shock—Capecitabine—stomach cancer	0.000125	0.00109	CcSEcCtD
Pentoxifylline—Conjunctivitis—Doxorubicin—stomach cancer	0.000125	0.00109	CcSEcCtD
Pentoxifylline—Haemorrhage—Epirubicin—stomach cancer	0.000124	0.00108	CcSEcCtD
Pentoxifylline—Hepatitis—Epirubicin—stomach cancer	0.000124	0.00108	CcSEcCtD
Pentoxifylline—Diarrhoea—Fluorouracil—stomach cancer	0.000124	0.00108	CcSEcCtD
Pentoxifylline—Thrombocytopenia—Capecitabine—stomach cancer	0.000124	0.00108	CcSEcCtD
Pentoxifylline—Tachycardia—Capecitabine—stomach cancer	0.000124	0.00108	CcSEcCtD
Pentoxifylline—Skin disorder—Capecitabine—stomach cancer	0.000123	0.00107	CcSEcCtD
Pentoxifylline—Sweating—Doxorubicin—stomach cancer	0.000123	0.00107	CcSEcCtD
Pentoxifylline—Hyperhidrosis—Capecitabine—stomach cancer	0.000123	0.00107	CcSEcCtD
Pentoxifylline—Hypotension—Docetaxel—stomach cancer	0.000122	0.00107	CcSEcCtD
Pentoxifylline—Hepatobiliary disease—Doxorubicin—stomach cancer	0.000121	0.00106	CcSEcCtD
Pentoxifylline—Epistaxis—Doxorubicin—stomach cancer	0.000121	0.00105	CcSEcCtD
Pentoxifylline—Anorexia—Capecitabine—stomach cancer	0.000121	0.00105	CcSEcCtD
Pentoxifylline—Vomiting—Irinotecan—stomach cancer	0.00012	0.00105	CcSEcCtD
Pentoxifylline—Immune system disorder—Methotrexate—stomach cancer	0.00012	0.00105	CcSEcCtD
Pentoxifylline—Dizziness—Fluorouracil—stomach cancer	0.00012	0.00105	CcSEcCtD
Pentoxifylline—Rash—Irinotecan—stomach cancer	0.000119	0.00104	CcSEcCtD
Pentoxifylline—Dermatitis—Irinotecan—stomach cancer	0.000119	0.00104	CcSEcCtD
Pentoxifylline—Musculoskeletal discomfort—Docetaxel—stomach cancer	0.000119	0.00104	CcSEcCtD
Pentoxifylline—Headache—Irinotecan—stomach cancer	0.000119	0.00103	CcSEcCtD
Pentoxifylline—Hypotension—Capecitabine—stomach cancer	0.000119	0.00103	CcSEcCtD
Pentoxifylline—Insomnia—Docetaxel—stomach cancer	0.000118	0.00103	CcSEcCtD
Pentoxifylline—Dyspnoea—Docetaxel—stomach cancer	0.000117	0.00102	CcSEcCtD
Pentoxifylline—Somnolence—Docetaxel—stomach cancer	0.000116	0.00102	CcSEcCtD
Pentoxifylline—Erythema—Methotrexate—stomach cancer	0.000116	0.00101	CcSEcCtD
Pentoxifylline—Haemoglobin—Doxorubicin—stomach cancer	0.000116	0.00101	CcSEcCtD
Pentoxifylline—Musculoskeletal discomfort—Capecitabine—stomach cancer	0.000116	0.00101	CcSEcCtD
Pentoxifylline—Flushing—Epirubicin—stomach cancer	0.000115	0.00101	CcSEcCtD
Pentoxifylline—Vomiting—Fluorouracil—stomach cancer	0.000115	0.00101	CcSEcCtD
Pentoxifylline—Dyspepsia—Docetaxel—stomach cancer	0.000115	0.00101	CcSEcCtD
Pentoxifylline—Haemorrhage—Doxorubicin—stomach cancer	0.000115	0.001	CcSEcCtD
Pentoxifylline—Hepatitis—Doxorubicin—stomach cancer	0.000115	0.001	CcSEcCtD
Pentoxifylline—Insomnia—Capecitabine—stomach cancer	0.000115	0.001	CcSEcCtD
Pentoxifylline—Rash—Fluorouracil—stomach cancer	0.000114	0.000997	CcSEcCtD
Pentoxifylline—Dermatitis—Fluorouracil—stomach cancer	0.000114	0.000997	CcSEcCtD
Pentoxifylline—Decreased appetite—Docetaxel—stomach cancer	0.000114	0.000993	CcSEcCtD
Pentoxifylline—Headache—Fluorouracil—stomach cancer	0.000114	0.000991	CcSEcCtD
Pentoxifylline—Dysgeusia—Methotrexate—stomach cancer	0.000113	0.000987	CcSEcCtD
Pentoxifylline—Dyspnoea—Capecitabine—stomach cancer	0.000113	0.000986	CcSEcCtD
Pentoxifylline—Nausea—Irinotecan—stomach cancer	0.000113	0.000981	CcSEcCtD
Pentoxifylline—Immune system disorder—Epirubicin—stomach cancer	0.000112	0.000979	CcSEcCtD
Pentoxifylline—Constipation—Docetaxel—stomach cancer	0.000112	0.000976	CcSEcCtD
Pentoxifylline—Back pain—Methotrexate—stomach cancer	0.000112	0.000975	CcSEcCtD
Pentoxifylline—Dyspepsia—Capecitabine—stomach cancer	0.000112	0.000973	CcSEcCtD
Pentoxifylline—Arrhythmia—Epirubicin—stomach cancer	0.000111	0.000968	CcSEcCtD
Pentoxifylline—Decreased appetite—Capecitabine—stomach cancer	0.00011	0.000961	CcSEcCtD
Pentoxifylline—Vision blurred—Methotrexate—stomach cancer	0.000109	0.00095	CcSEcCtD
Pentoxifylline—Constipation—Capecitabine—stomach cancer	0.000108	0.000945	CcSEcCtD
Pentoxifylline—Erythema—Epirubicin—stomach cancer	0.000108	0.000944	CcSEcCtD
Pentoxifylline—Feeling abnormal—Docetaxel—stomach cancer	0.000108	0.000941	CcSEcCtD
Pentoxifylline—Nausea—Fluorouracil—stomach cancer	0.000108	0.00094	CcSEcCtD
Pentoxifylline—Ill-defined disorder—Methotrexate—stomach cancer	0.000107	0.000936	CcSEcCtD
Pentoxifylline—Gastrointestinal pain—Docetaxel—stomach cancer	0.000107	0.000934	CcSEcCtD
Pentoxifylline—Anaemia—Methotrexate—stomach cancer	0.000107	0.000932	CcSEcCtD
Pentoxifylline—Flushing—Doxorubicin—stomach cancer	0.000107	0.000931	CcSEcCtD
Pentoxifylline—Flatulence—Epirubicin—stomach cancer	0.000107	0.00093	CcSEcCtD
Pentoxifylline—Tension—Epirubicin—stomach cancer	0.000106	0.000926	CcSEcCtD
Pentoxifylline—Dysgeusia—Epirubicin—stomach cancer	0.000106	0.000924	CcSEcCtD
Pentoxifylline—Nervousness—Epirubicin—stomach cancer	0.000105	0.000917	CcSEcCtD
Pentoxifylline—Back pain—Epirubicin—stomach cancer	0.000105	0.000913	CcSEcCtD
Pentoxifylline—Feeling abnormal—Capecitabine—stomach cancer	0.000105	0.000911	CcSEcCtD
Pentoxifylline—Malaise—Methotrexate—stomach cancer	0.000104	0.000909	CcSEcCtD
Pentoxifylline—Muscle spasms—Epirubicin—stomach cancer	0.000104	0.000907	CcSEcCtD
Pentoxifylline—Immune system disorder—Doxorubicin—stomach cancer	0.000104	0.000906	CcSEcCtD
Pentoxifylline—Gastrointestinal pain—Capecitabine—stomach cancer	0.000104	0.000904	CcSEcCtD
Pentoxifylline—Abdominal pain—Docetaxel—stomach cancer	0.000104	0.000903	CcSEcCtD
Pentoxifylline—Body temperature increased—Docetaxel—stomach cancer	0.000104	0.000903	CcSEcCtD
Pentoxifylline—Leukopenia—Methotrexate—stomach cancer	0.000104	0.000903	CcSEcCtD
Pentoxifylline—Arrhythmia—Doxorubicin—stomach cancer	0.000103	0.000896	CcSEcCtD
Pentoxifylline—Vision blurred—Epirubicin—stomach cancer	0.000102	0.000889	CcSEcCtD
Pentoxifylline—Urticaria—Capecitabine—stomach cancer	0.000101	0.000878	CcSEcCtD
Pentoxifylline—Ill-defined disorder—Epirubicin—stomach cancer	0.0001	0.000876	CcSEcCtD
Pentoxifylline—Body temperature increased—Capecitabine—stomach cancer	0.0001	0.000874	CcSEcCtD
Pentoxifylline—Abdominal pain—Capecitabine—stomach cancer	0.0001	0.000874	CcSEcCtD
Pentoxifylline—Convulsion—Methotrexate—stomach cancer	0.0001	0.000874	CcSEcCtD
Pentoxifylline—Erythema—Doxorubicin—stomach cancer	0.0001	0.000873	CcSEcCtD
Pentoxifylline—Anaemia—Epirubicin—stomach cancer	0.0001	0.000872	CcSEcCtD
Pentoxifylline—Agitation—Epirubicin—stomach cancer	9.95e-05	0.000867	CcSEcCtD
Pentoxifylline—Flatulence—Doxorubicin—stomach cancer	9.87e-05	0.00086	CcSEcCtD
Pentoxifylline—Chest pain—Methotrexate—stomach cancer	9.85e-05	0.000858	CcSEcCtD
Pentoxifylline—Myalgia—Methotrexate—stomach cancer	9.85e-05	0.000858	CcSEcCtD
Pentoxifylline—Tension—Doxorubicin—stomach cancer	9.83e-05	0.000857	CcSEcCtD
Pentoxifylline—Dysgeusia—Doxorubicin—stomach cancer	9.81e-05	0.000855	CcSEcCtD
Pentoxifylline—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—stomach cancer	9.78e-05	0.000853	CcSEcCtD
Pentoxifylline—Malaise—Epirubicin—stomach cancer	9.76e-05	0.000851	CcSEcCtD
Pentoxifylline—Discomfort—Methotrexate—stomach cancer	9.73e-05	0.000848	CcSEcCtD
Pentoxifylline—Nervousness—Doxorubicin—stomach cancer	9.73e-05	0.000848	CcSEcCtD
Pentoxifylline—Leukopenia—Epirubicin—stomach cancer	9.69e-05	0.000845	CcSEcCtD
Pentoxifylline—Back pain—Doxorubicin—stomach cancer	9.69e-05	0.000845	CcSEcCtD
Pentoxifylline—Hypersensitivity—Docetaxel—stomach cancer	9.65e-05	0.000841	CcSEcCtD
Pentoxifylline—Muscle spasms—Doxorubicin—stomach cancer	9.63e-05	0.000839	CcSEcCtD
Pentoxifylline—Palpitations—Epirubicin—stomach cancer	9.57e-05	0.000834	CcSEcCtD
Pentoxifylline—Confusional state—Methotrexate—stomach cancer	9.52e-05	0.00083	CcSEcCtD
Pentoxifylline—Anaphylactic shock—Methotrexate—stomach cancer	9.44e-05	0.000823	CcSEcCtD
Pentoxifylline—Vision blurred—Doxorubicin—stomach cancer	9.44e-05	0.000823	CcSEcCtD
Pentoxifylline—Asthenia—Docetaxel—stomach cancer	9.4e-05	0.000819	CcSEcCtD
Pentoxifylline—Convulsion—Epirubicin—stomach cancer	9.38e-05	0.000818	CcSEcCtD
Pentoxifylline—Infection—Methotrexate—stomach cancer	9.38e-05	0.000818	CcSEcCtD
Pentoxifylline—Hypertension—Epirubicin—stomach cancer	9.35e-05	0.000815	CcSEcCtD
Pentoxifylline—Hypersensitivity—Capecitabine—stomach cancer	9.34e-05	0.000815	CcSEcCtD
Pentoxifylline—Ill-defined disorder—Doxorubicin—stomach cancer	9.29e-05	0.00081	CcSEcCtD
Pentoxifylline—Pruritus—Docetaxel—stomach cancer	9.27e-05	0.000808	CcSEcCtD
Pentoxifylline—Anaemia—Doxorubicin—stomach cancer	9.26e-05	0.000807	CcSEcCtD
Pentoxifylline—Thrombocytopenia—Methotrexate—stomach cancer	9.24e-05	0.000806	CcSEcCtD
Pentoxifylline—Myalgia—Epirubicin—stomach cancer	9.22e-05	0.000803	CcSEcCtD
Pentoxifylline—Chest pain—Epirubicin—stomach cancer	9.22e-05	0.000803	CcSEcCtD
Pentoxifylline—Agitation—Doxorubicin—stomach cancer	9.21e-05	0.000802	CcSEcCtD
Pentoxifylline—Anxiety—Epirubicin—stomach cancer	9.19e-05	0.000801	CcSEcCtD
Pentoxifylline—Skin disorder—Methotrexate—stomach cancer	9.17e-05	0.000799	CcSEcCtD
Pentoxifylline—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—stomach cancer	9.15e-05	0.000798	CcSEcCtD
Pentoxifylline—Hyperhidrosis—Methotrexate—stomach cancer	9.13e-05	0.000796	CcSEcCtD
Pentoxifylline—Discomfort—Epirubicin—stomach cancer	9.11e-05	0.000794	CcSEcCtD
Pentoxifylline—Asthenia—Capecitabine—stomach cancer	9.1e-05	0.000793	CcSEcCtD
Pentoxifylline—Malaise—Doxorubicin—stomach cancer	9.03e-05	0.000787	CcSEcCtD
Pentoxifylline—Dry mouth—Epirubicin—stomach cancer	9.01e-05	0.000786	CcSEcCtD
Pentoxifylline—Anorexia—Methotrexate—stomach cancer	9e-05	0.000784	CcSEcCtD
Pentoxifylline—Pruritus—Capecitabine—stomach cancer	8.97e-05	0.000782	CcSEcCtD
Pentoxifylline—Leukopenia—Doxorubicin—stomach cancer	8.97e-05	0.000782	CcSEcCtD
Pentoxifylline—Diarrhoea—Docetaxel—stomach cancer	8.96e-05	0.000781	CcSEcCtD
Pentoxifylline—Confusional state—Epirubicin—stomach cancer	8.91e-05	0.000777	CcSEcCtD
Pentoxifylline—Palpitations—Doxorubicin—stomach cancer	8.85e-05	0.000772	CcSEcCtD
Pentoxifylline—Anaphylactic shock—Epirubicin—stomach cancer	8.84e-05	0.00077	CcSEcCtD
Pentoxifylline—Oedema—Epirubicin—stomach cancer	8.84e-05	0.00077	CcSEcCtD
Pentoxifylline—Hypotension—Methotrexate—stomach cancer	8.82e-05	0.000769	CcSEcCtD
Pentoxifylline—Infection—Epirubicin—stomach cancer	8.78e-05	0.000765	CcSEcCtD
Pentoxifylline—Shock—Epirubicin—stomach cancer	8.69e-05	0.000758	CcSEcCtD
Pentoxifylline—Convulsion—Doxorubicin—stomach cancer	8.68e-05	0.000757	CcSEcCtD
Pentoxifylline—Diarrhoea—Capecitabine—stomach cancer	8.68e-05	0.000756	CcSEcCtD
Pentoxifylline—Dizziness—Docetaxel—stomach cancer	8.66e-05	0.000755	CcSEcCtD
Pentoxifylline—Thrombocytopenia—Epirubicin—stomach cancer	8.65e-05	0.000754	CcSEcCtD
Pentoxifylline—Hypertension—Doxorubicin—stomach cancer	8.65e-05	0.000754	CcSEcCtD
Pentoxifylline—Tachycardia—Epirubicin—stomach cancer	8.62e-05	0.000752	CcSEcCtD
Pentoxifylline—Musculoskeletal discomfort—Methotrexate—stomach cancer	8.6e-05	0.00075	CcSEcCtD
Pentoxifylline—Skin disorder—Epirubicin—stomach cancer	8.58e-05	0.000748	CcSEcCtD
Pentoxifylline—Hyperhidrosis—Epirubicin—stomach cancer	8.54e-05	0.000745	CcSEcCtD
Pentoxifylline—Insomnia—Methotrexate—stomach cancer	8.54e-05	0.000744	CcSEcCtD
Pentoxifylline—Myalgia—Doxorubicin—stomach cancer	8.53e-05	0.000743	CcSEcCtD
Pentoxifylline—Chest pain—Doxorubicin—stomach cancer	8.53e-05	0.000743	CcSEcCtD
Pentoxifylline—Anxiety—Doxorubicin—stomach cancer	8.5e-05	0.000741	CcSEcCtD
Pentoxifylline—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—stomach cancer	8.47e-05	0.000738	CcSEcCtD
Pentoxifylline—Discomfort—Doxorubicin—stomach cancer	8.43e-05	0.000734	CcSEcCtD
Pentoxifylline—Anorexia—Epirubicin—stomach cancer	8.42e-05	0.000734	CcSEcCtD
Pentoxifylline—Dyspnoea—Methotrexate—stomach cancer	8.42e-05	0.000734	CcSEcCtD
Pentoxifylline—Somnolence—Methotrexate—stomach cancer	8.39e-05	0.000732	CcSEcCtD
Pentoxifylline—Dizziness—Capecitabine—stomach cancer	8.39e-05	0.000731	CcSEcCtD
Pentoxifylline—Dry mouth—Doxorubicin—stomach cancer	8.34e-05	0.000727	CcSEcCtD
Pentoxifylline—Vomiting—Docetaxel—stomach cancer	8.33e-05	0.000726	CcSEcCtD
Pentoxifylline—Dyspepsia—Methotrexate—stomach cancer	8.31e-05	0.000724	CcSEcCtD
Pentoxifylline—Rash—Docetaxel—stomach cancer	8.26e-05	0.00072	CcSEcCtD
Pentoxifylline—Hypotension—Epirubicin—stomach cancer	8.26e-05	0.00072	CcSEcCtD
Pentoxifylline—Dermatitis—Docetaxel—stomach cancer	8.25e-05	0.000719	CcSEcCtD
Pentoxifylline—Confusional state—Doxorubicin—stomach cancer	8.24e-05	0.000719	CcSEcCtD
Pentoxifylline—Decreased appetite—Methotrexate—stomach cancer	8.21e-05	0.000715	CcSEcCtD
Pentoxifylline—Headache—Docetaxel—stomach cancer	8.21e-05	0.000715	CcSEcCtD
Pentoxifylline—Anaphylactic shock—Doxorubicin—stomach cancer	8.18e-05	0.000713	CcSEcCtD
Pentoxifylline—Oedema—Doxorubicin—stomach cancer	8.18e-05	0.000713	CcSEcCtD
Pentoxifylline—Infection—Doxorubicin—stomach cancer	8.12e-05	0.000708	CcSEcCtD
Pentoxifylline—Vomiting—Capecitabine—stomach cancer	8.06e-05	0.000703	CcSEcCtD
Pentoxifylline—Musculoskeletal discomfort—Epirubicin—stomach cancer	8.05e-05	0.000702	CcSEcCtD
Pentoxifylline—Shock—Doxorubicin—stomach cancer	8.04e-05	0.000701	CcSEcCtD
Pentoxifylline—Thrombocytopenia—Doxorubicin—stomach cancer	8.01e-05	0.000698	CcSEcCtD
Pentoxifylline—Rash—Capecitabine—stomach cancer	8e-05	0.000697	CcSEcCtD
Pentoxifylline—Insomnia—Epirubicin—stomach cancer	7.99e-05	0.000697	CcSEcCtD
Pentoxifylline—Dermatitis—Capecitabine—stomach cancer	7.99e-05	0.000696	CcSEcCtD
Pentoxifylline—Tachycardia—Doxorubicin—stomach cancer	7.98e-05	0.000696	CcSEcCtD
Pentoxifylline—Headache—Capecitabine—stomach cancer	7.95e-05	0.000693	CcSEcCtD
Pentoxifylline—Skin disorder—Doxorubicin—stomach cancer	7.94e-05	0.000692	CcSEcCtD
Pentoxifylline—Hyperhidrosis—Doxorubicin—stomach cancer	7.9e-05	0.000689	CcSEcCtD
Pentoxifylline—Dyspnoea—Epirubicin—stomach cancer	7.88e-05	0.000687	CcSEcCtD
Pentoxifylline—Somnolence—Epirubicin—stomach cancer	7.86e-05	0.000685	CcSEcCtD
Pentoxifylline—Anorexia—Doxorubicin—stomach cancer	7.79e-05	0.000679	CcSEcCtD
Pentoxifylline—Nausea—Docetaxel—stomach cancer	7.78e-05	0.000678	CcSEcCtD
Pentoxifylline—Feeling abnormal—Methotrexate—stomach cancer	7.78e-05	0.000678	CcSEcCtD
Pentoxifylline—Dyspepsia—Epirubicin—stomach cancer	7.78e-05	0.000678	CcSEcCtD
Pentoxifylline—Gastrointestinal pain—Methotrexate—stomach cancer	7.72e-05	0.000673	CcSEcCtD
Pentoxifylline—Decreased appetite—Epirubicin—stomach cancer	7.68e-05	0.00067	CcSEcCtD
Pentoxifylline—Hypotension—Doxorubicin—stomach cancer	7.64e-05	0.000666	CcSEcCtD
Pentoxifylline—Constipation—Epirubicin—stomach cancer	7.56e-05	0.000659	CcSEcCtD
Pentoxifylline—Nausea—Capecitabine—stomach cancer	7.53e-05	0.000657	CcSEcCtD
Pentoxifylline—Urticaria—Methotrexate—stomach cancer	7.5e-05	0.000654	CcSEcCtD
Pentoxifylline—Abdominal pain—Methotrexate—stomach cancer	7.46e-05	0.000651	CcSEcCtD
Pentoxifylline—Body temperature increased—Methotrexate—stomach cancer	7.46e-05	0.000651	CcSEcCtD
Pentoxifylline—Musculoskeletal discomfort—Doxorubicin—stomach cancer	7.45e-05	0.000649	CcSEcCtD
Pentoxifylline—Insomnia—Doxorubicin—stomach cancer	7.39e-05	0.000645	CcSEcCtD
Pentoxifylline—Dyspnoea—Doxorubicin—stomach cancer	7.29e-05	0.000635	CcSEcCtD
Pentoxifylline—Feeling abnormal—Epirubicin—stomach cancer	7.28e-05	0.000635	CcSEcCtD
Pentoxifylline—Somnolence—Doxorubicin—stomach cancer	7.27e-05	0.000634	CcSEcCtD
Pentoxifylline—Gastrointestinal pain—Epirubicin—stomach cancer	7.23e-05	0.00063	CcSEcCtD
Pentoxifylline—Dyspepsia—Doxorubicin—stomach cancer	7.2e-05	0.000627	CcSEcCtD
Pentoxifylline—Decreased appetite—Doxorubicin—stomach cancer	7.11e-05	0.000619	CcSEcCtD
Pentoxifylline—Urticaria—Epirubicin—stomach cancer	7.02e-05	0.000612	CcSEcCtD
Pentoxifylline—Constipation—Doxorubicin—stomach cancer	6.99e-05	0.000609	CcSEcCtD
Pentoxifylline—Abdominal pain—Epirubicin—stomach cancer	6.99e-05	0.000609	CcSEcCtD
Pentoxifylline—Body temperature increased—Epirubicin—stomach cancer	6.99e-05	0.000609	CcSEcCtD
Pentoxifylline—Hypersensitivity—Methotrexate—stomach cancer	6.96e-05	0.000606	CcSEcCtD
Pentoxifylline—Asthenia—Methotrexate—stomach cancer	6.77e-05	0.00059	CcSEcCtD
Pentoxifylline—Feeling abnormal—Doxorubicin—stomach cancer	6.74e-05	0.000587	CcSEcCtD
Pentoxifylline—Gastrointestinal pain—Doxorubicin—stomach cancer	6.69e-05	0.000583	CcSEcCtD
Pentoxifylline—Pruritus—Methotrexate—stomach cancer	6.68e-05	0.000582	CcSEcCtD
Pentoxifylline—Hypersensitivity—Epirubicin—stomach cancer	6.51e-05	0.000567	CcSEcCtD
Pentoxifylline—Urticaria—Doxorubicin—stomach cancer	6.5e-05	0.000566	CcSEcCtD
Pentoxifylline—Abdominal pain—Doxorubicin—stomach cancer	6.46e-05	0.000563	CcSEcCtD
Pentoxifylline—Body temperature increased—Doxorubicin—stomach cancer	6.46e-05	0.000563	CcSEcCtD
Pentoxifylline—Diarrhoea—Methotrexate—stomach cancer	6.46e-05	0.000563	CcSEcCtD
Pentoxifylline—Asthenia—Epirubicin—stomach cancer	6.34e-05	0.000553	CcSEcCtD
Pentoxifylline—Pruritus—Epirubicin—stomach cancer	6.25e-05	0.000545	CcSEcCtD
Pentoxifylline—Dizziness—Methotrexate—stomach cancer	6.24e-05	0.000544	CcSEcCtD
Pentoxifylline—Diarrhoea—Epirubicin—stomach cancer	6.05e-05	0.000527	CcSEcCtD
Pentoxifylline—Hypersensitivity—Doxorubicin—stomach cancer	6.02e-05	0.000525	CcSEcCtD
Pentoxifylline—Vomiting—Methotrexate—stomach cancer	6e-05	0.000523	CcSEcCtD
Pentoxifylline—Rash—Methotrexate—stomach cancer	5.95e-05	0.000519	CcSEcCtD
Pentoxifylline—Dermatitis—Methotrexate—stomach cancer	5.95e-05	0.000518	CcSEcCtD
Pentoxifylline—Headache—Methotrexate—stomach cancer	5.92e-05	0.000516	CcSEcCtD
Pentoxifylline—Asthenia—Doxorubicin—stomach cancer	5.87e-05	0.000511	CcSEcCtD
Pentoxifylline—Dizziness—Epirubicin—stomach cancer	5.84e-05	0.000509	CcSEcCtD
Pentoxifylline—Pruritus—Doxorubicin—stomach cancer	5.78e-05	0.000504	CcSEcCtD
Pentoxifylline—Vomiting—Epirubicin—stomach cancer	5.62e-05	0.00049	CcSEcCtD
Pentoxifylline—Nausea—Methotrexate—stomach cancer	5.61e-05	0.000489	CcSEcCtD
Pentoxifylline—Diarrhoea—Doxorubicin—stomach cancer	5.59e-05	0.000488	CcSEcCtD
Pentoxifylline—Rash—Epirubicin—stomach cancer	5.57e-05	0.000486	CcSEcCtD
Pentoxifylline—Dermatitis—Epirubicin—stomach cancer	5.57e-05	0.000485	CcSEcCtD
Pentoxifylline—Headache—Epirubicin—stomach cancer	5.54e-05	0.000482	CcSEcCtD
Pentoxifylline—Dizziness—Doxorubicin—stomach cancer	5.41e-05	0.000471	CcSEcCtD
Pentoxifylline—Nausea—Epirubicin—stomach cancer	5.25e-05	0.000457	CcSEcCtD
Pentoxifylline—Vomiting—Doxorubicin—stomach cancer	5.2e-05	0.000453	CcSEcCtD
Pentoxifylline—Rash—Doxorubicin—stomach cancer	5.16e-05	0.000449	CcSEcCtD
Pentoxifylline—Dermatitis—Doxorubicin—stomach cancer	5.15e-05	0.000449	CcSEcCtD
Pentoxifylline—Headache—Doxorubicin—stomach cancer	5.12e-05	0.000446	CcSEcCtD
Pentoxifylline—Nausea—Doxorubicin—stomach cancer	4.86e-05	0.000423	CcSEcCtD
Pentoxifylline—PDE4B—Signaling Pathways—FYN—stomach cancer	1.45e-05	0.000169	CbGpPWpGaD
Pentoxifylline—NT5E—Metabolism—PIK3CA—stomach cancer	1.45e-05	0.000169	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—CAV1—stomach cancer	1.44e-05	0.000168	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—APOA1—stomach cancer	1.44e-05	0.000167	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—HBEGF—stomach cancer	1.42e-05	0.000166	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—PGLS—stomach cancer	1.42e-05	0.000166	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—BLVRB—stomach cancer	1.42e-05	0.000166	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling by GPCR—CXCL8—stomach cancer	1.39e-05	0.000162	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—FGFR2—stomach cancer	1.38e-05	0.000161	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling by GPCR—CXCL8—stomach cancer	1.37e-05	0.00016	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—PRKCB—stomach cancer	1.37e-05	0.00016	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—IL6ST—stomach cancer	1.37e-05	0.000159	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—FGFR2—stomach cancer	1.36e-05	0.000159	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—PPAP2A—stomach cancer	1.36e-05	0.000158	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—IL6R—stomach cancer	1.35e-05	0.000158	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—IRS2—stomach cancer	1.35e-05	0.000157	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR downstream signaling—RHOA—stomach cancer	1.35e-05	0.000157	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—ADRB2—stomach cancer	1.31e-05	0.000153	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—APC—stomach cancer	1.31e-05	0.000153	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—CAV1—stomach cancer	1.31e-05	0.000152	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C3—stomach cancer	1.31e-05	0.000152	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—APOA1—stomach cancer	1.31e-05	0.000152	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—PPP2R1A—stomach cancer	1.29e-05	0.00015	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—IRS2—stomach cancer	1.26e-05	0.000147	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling by GPCR—MAPK3—stomach cancer	1.26e-05	0.000146	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—IRS2—stomach cancer	1.25e-05	0.000145	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—PRKCB—stomach cancer	1.25e-05	0.000145	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—IL6ST—stomach cancer	1.24e-05	0.000144	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—CAV1—stomach cancer	1.23e-05	0.000143	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—RHOA—stomach cancer	1.22e-05	0.000142	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—APOA1—stomach cancer	1.22e-05	0.000142	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—IL6R—stomach cancer	1.22e-05	0.000142	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—CAV1—stomach cancer	1.21e-05	0.000141	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—CA1—stomach cancer	1.21e-05	0.000141	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—NDUFA2—stomach cancer	1.21e-05	0.000141	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—CKB—stomach cancer	1.21e-05	0.000141	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—FBP1—stomach cancer	1.21e-05	0.000141	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—APOA1—stomach cancer	1.21e-05	0.000141	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling by GPCR—MAPK1—stomach cancer	1.2e-05	0.000139	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling by GPCR—EGFR—stomach cancer	1.2e-05	0.000139	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—SMAD4—stomach cancer	1.2e-05	0.000139	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—APC—stomach cancer	1.19e-05	0.000139	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR downstream signaling—CXCL8—stomach cancer	1.18e-05	0.000138	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—PRKCB—stomach cancer	1.17e-05	0.000136	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—IL6ST—stomach cancer	1.16e-05	0.000135	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—PRKCB—stomach cancer	1.15e-05	0.000134	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—IL6ST—stomach cancer	1.15e-05	0.000134	CbGpPWpGaD
Pentoxifylline—ADORA2B—GPCR downstream signaling—PIK3CA—stomach cancer	1.14e-05	0.000133	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling by GPCR—MAPK3—stomach cancer	1.14e-05	0.000133	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—SERPINE1—stomach cancer	1.14e-05	0.000133	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—PLIN2—stomach cancer	1.14e-05	0.000132	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—FYN—stomach cancer	1.14e-05	0.000132	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling by GPCR—KRAS—stomach cancer	1.13e-05	0.000131	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—APC—stomach cancer	1.12e-05	0.00013	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—CA2—stomach cancer	1.11e-05	0.000129	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—IL6R—stomach cancer	1.11e-05	0.000129	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—APC—stomach cancer	1.1e-05	0.000128	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—RHOA—stomach cancer	1.1e-05	0.000128	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—NOS3—stomach cancer	1.09e-05	0.000127	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling by GPCR—MAPK1—stomach cancer	1.09e-05	0.000126	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling by GPCR—EGFR—stomach cancer	1.09e-05	0.000126	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—NT5E—stomach cancer	1.08e-05	0.000126	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—PGAM1—stomach cancer	1.08e-05	0.000126	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—CXCL8—stomach cancer	1.07e-05	0.000125	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling by GPCR—MAPK3—stomach cancer	1.07e-05	0.000124	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—FGFR2—stomach cancer	1.07e-05	0.000124	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling by GPCR—MAPK3—stomach cancer	1.06e-05	0.000123	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling by GPCR—PIK3CA—stomach cancer	1.04e-05	0.000121	CbGpPWpGaD
Pentoxifylline—PDE4A—GPCR downstream signaling—PIK3CA—stomach cancer	1.04e-05	0.000121	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—SERPINE1—stomach cancer	1.04e-05	0.000121	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—IL6R—stomach cancer	1.04e-05	0.000121	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—ALDH7A1—stomach cancer	1.03e-05	0.00012	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—PLCE1—stomach cancer	1.03e-05	0.00012	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling by GPCR—KRAS—stomach cancer	1.03e-05	0.000119	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—IL6R—stomach cancer	1.02e-05	0.000119	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—ERBB2—stomach cancer	1.02e-05	0.000119	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling by GPCR—MAPK1—stomach cancer	1.02e-05	0.000118	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling by GPCR—EGFR—stomach cancer	1.02e-05	0.000118	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling by GPCR—MAPK1—stomach cancer	1.01e-05	0.000117	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling by GPCR—EGFR—stomach cancer	1e-05	0.000117	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—RHOA—stomach cancer	1e-05	0.000116	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—NOS3—stomach cancer	9.9e-06	0.000115	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—UMPS—stomach cancer	9.87e-06	0.000115	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—IRS2—stomach cancer	9.76e-06	0.000114	CbGpPWpGaD
Pentoxifylline—ADORA1—GPCR downstream signaling—PIK3CA—stomach cancer	9.72e-06	0.000113	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—SERPINE1—stomach cancer	9.71e-06	0.000113	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—CXCL8—stomach cancer	9.67e-06	0.000112	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling by GPCR—KRAS—stomach cancer	9.61e-06	0.000112	CbGpPWpGaD
Pentoxifylline—PDE4B—GPCR downstream signaling—PIK3CA—stomach cancer	9.61e-06	0.000112	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling by GPCR—HRAS—stomach cancer	9.6e-06	0.000112	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—SERPINE1—stomach cancer	9.59e-06	0.000112	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling by GPCR—KRAS—stomach cancer	9.49e-06	0.00011	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—CAV1—stomach cancer	9.46e-06	0.00011	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—APOA1—stomach cancer	9.44e-06	0.00011	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—CDKN1B—stomach cancer	9.44e-06	0.00011	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling by GPCR—PIK3CA—stomach cancer	9.43e-06	0.00011	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—RHOA—stomach cancer	9.36e-06	0.000109	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—NOS3—stomach cancer	9.27e-06	0.000108	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—ERBB2—stomach cancer	9.26e-06	0.000108	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—RHOA—stomach cancer	9.25e-06	0.000108	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling by GPCR—IL6—stomach cancer	9.19e-06	0.000107	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—PDHA1—stomach cancer	9.17e-06	0.000107	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—ECHS1—stomach cancer	9.17e-06	0.000107	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—NOS3—stomach cancer	9.16e-06	0.000107	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—PRKCB—stomach cancer	9.01e-06	0.000105	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—CCND1—stomach cancer	9.01e-06	0.000105	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—JUN—stomach cancer	8.99e-06	0.000105	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—IL6ST—stomach cancer	8.97e-06	0.000104	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling by GPCR—PIK3CA—stomach cancer	8.83e-06	0.000103	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—CXCL8—stomach cancer	8.78e-06	0.000102	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—MMP9—stomach cancer	8.74e-06	0.000102	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling by GPCR—PIK3CA—stomach cancer	8.72e-06	0.000101	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling by GPCR—HRAS—stomach cancer	8.72e-06	0.000101	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—CDKN1A—stomach cancer	8.71e-06	0.000101	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—ERBB2—stomach cancer	8.67e-06	0.000101	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—TYMP—stomach cancer	8.63e-06	0.0001	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—FADS1—stomach cancer	8.63e-06	0.0001	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—APC—stomach cancer	8.62e-06	0.0001	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—CDKN1B—stomach cancer	8.57e-06	9.97e-05	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—ERBB2—stomach cancer	8.56e-06	9.96e-05	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—MAPK8—stomach cancer	8.5e-06	9.89e-05	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling by GPCR—IL6—stomach cancer	8.35e-06	9.71e-05	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—MAPK3—stomach cancer	8.25e-06	9.6e-05	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—CXCL8—stomach cancer	8.22e-06	9.56e-05	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—CCND1—stomach cancer	8.18e-06	9.51e-05	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling by GPCR—HRAS—stomach cancer	8.17e-06	9.5e-05	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—JUN—stomach cancer	8.16e-06	9.49e-05	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—CXCL8—stomach cancer	8.12e-06	9.45e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—SREBF2—stomach cancer	8.08e-06	9.4e-05	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling by GPCR—HRAS—stomach cancer	8.07e-06	9.39e-05	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—CDKN1B—stomach cancer	8.03e-06	9.34e-05	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—IL6R—stomach cancer	8e-06	9.31e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—RORA—stomach cancer	7.98e-06	9.29e-05	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—MMP9—stomach cancer	7.94e-06	9.24e-05	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—CDKN1B—stomach cancer	7.93e-06	9.23e-05	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—CDKN1A—stomach cancer	7.91e-06	9.2e-05	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—MAPK1—stomach cancer	7.85e-06	9.14e-05	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—EGFR—stomach cancer	7.85e-06	9.14e-05	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—VEGFA—stomach cancer	7.85e-06	9.13e-05	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling by GPCR—IL6—stomach cancer	7.82e-06	9.09e-05	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—STAT3—stomach cancer	7.77e-06	9.04e-05	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling by GPCR—IL6—stomach cancer	7.72e-06	8.99e-05	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—MAPK8—stomach cancer	7.72e-06	8.98e-05	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—CCND1—stomach cancer	7.66e-06	8.91e-05	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—JUN—stomach cancer	7.64e-06	8.89e-05	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—CCND1—stomach cancer	7.57e-06	8.8e-05	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—JUN—stomach cancer	7.55e-06	8.78e-05	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR downstream signaling—PIK3CA—stomach cancer	7.51e-06	8.73e-05	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—SERPINE1—stomach cancer	7.49e-06	8.72e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—ALDOB—stomach cancer	7.48e-06	8.7e-05	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—MMP9—stomach cancer	7.43e-06	8.65e-05	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—MAPK3—stomach cancer	7.43e-06	8.64e-05	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—KRAS—stomach cancer	7.42e-06	8.63e-05	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—CDKN1A—stomach cancer	7.41e-06	8.62e-05	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—MMP9—stomach cancer	7.35e-06	8.55e-05	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—CDKN1A—stomach cancer	7.32e-06	8.52e-05	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—MAPK8—stomach cancer	7.23e-06	8.41e-05	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—RHOA—stomach cancer	7.23e-06	8.41e-05	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—MYC—stomach cancer	7.22e-06	8.4e-05	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—NOS3—stomach cancer	7.15e-06	8.32e-05	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—MAPK8—stomach cancer	7.14e-06	8.31e-05	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—VEGFA—stomach cancer	7.13e-06	8.29e-05	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—MAPK1—stomach cancer	7.07e-06	8.22e-05	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—EGFR—stomach cancer	7.07e-06	8.22e-05	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—STAT3—stomach cancer	7.06e-06	8.21e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—stomach cancer	7.05e-06	8.2e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—stomach cancer	7.04e-06	8.19e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—ALOX5—stomach cancer	6.95e-06	8.09e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—DPYD—stomach cancer	6.84e-06	7.96e-05	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—PIK3CA—stomach cancer	6.82e-06	7.93e-05	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—MAPK3—stomach cancer	6.74e-06	7.85e-05	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—ERBB2—stomach cancer	6.69e-06	7.79e-05	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—VEGFA—stomach cancer	6.68e-06	7.77e-05	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—KRAS—stomach cancer	6.68e-06	7.77e-05	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—STAT3—stomach cancer	6.61e-06	7.69e-05	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—VEGFA—stomach cancer	6.6e-06	7.67e-05	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—MYC—stomach cancer	6.56e-06	7.63e-05	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—STAT3—stomach cancer	6.53e-06	7.6e-05	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—MAPK1—stomach cancer	6.42e-06	7.47e-05	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—EGFR—stomach cancer	6.42e-06	7.46e-05	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—CXCL8—stomach cancer	6.35e-06	7.38e-05	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—MAPK3—stomach cancer	6.32e-06	7.35e-05	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—HRAS—stomach cancer	6.31e-06	7.34e-05	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—MAPK3—stomach cancer	6.24e-06	7.26e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—stomach cancer	6.2e-06	7.21e-05	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—CDKN1B—stomach cancer	6.2e-06	7.21e-05	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—MYC—stomach cancer	6.14e-06	7.15e-05	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—PIK3CA—stomach cancer	6.13e-06	7.13e-05	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—MYC—stomach cancer	6.07e-06	7.06e-05	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—KRAS—stomach cancer	6.06e-06	7.05e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—GSTT1—stomach cancer	6.05e-06	7.04e-05	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—IL6—stomach cancer	6.04e-06	7.02e-05	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—MAPK1—stomach cancer	6.01e-06	6.99e-05	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—EGFR—stomach cancer	6.01e-06	6.99e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—CYP2A6—stomach cancer	5.98e-06	6.96e-05	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—MAPK1—stomach cancer	5.94e-06	6.91e-05	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—EGFR—stomach cancer	5.94e-06	6.91e-05	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—TP53—stomach cancer	5.93e-06	6.9e-05	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—CCND1—stomach cancer	5.91e-06	6.88e-05	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—JUN—stomach cancer	5.9e-06	6.86e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—AKR1C3—stomach cancer	5.82e-06	6.77e-05	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—MMP9—stomach cancer	5.74e-06	6.68e-05	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—CDKN1A—stomach cancer	5.72e-06	6.65e-05	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—KRAS—stomach cancer	5.68e-06	6.6e-05	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—HRAS—stomach cancer	5.67e-06	6.6e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—ENO1—stomach cancer	5.67e-06	6.59e-05	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—KRAS—stomach cancer	5.61e-06	6.52e-05	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—MAPK8—stomach cancer	5.58e-06	6.49e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism of lipids and lipoproteins—ALB—stomach cancer	5.57e-06	6.49e-05	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—PIK3CA—stomach cancer	5.57e-06	6.48e-05	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—IL6—stomach cancer	5.43e-06	6.32e-05	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—TP53—stomach cancer	5.39e-06	6.27e-05	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—PIK3CA—stomach cancer	5.21e-06	6.07e-05	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—VEGFA—stomach cancer	5.15e-06	6e-05	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—PIK3CA—stomach cancer	5.15e-06	5.99e-05	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—HRAS—stomach cancer	5.15e-06	5.99e-05	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—STAT3—stomach cancer	5.1e-06	5.94e-05	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—TP53—stomach cancer	5.04e-06	5.87e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—CD44—stomach cancer	5.03e-06	5.85e-05	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—TP53—stomach cancer	4.98e-06	5.8e-05	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—IL6—stomach cancer	4.93e-06	5.74e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	4.88e-06	5.67e-05	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—MAPK3—stomach cancer	4.88e-06	5.67e-05	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—HRAS—stomach cancer	4.82e-06	5.61e-05	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—HRAS—stomach cancer	4.77e-06	5.55e-05	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—MYC—stomach cancer	4.74e-06	5.52e-05	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—MAPK1—stomach cancer	4.64e-06	5.4e-05	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—EGFR—stomach cancer	4.64e-06	5.4e-05	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—IL6—stomach cancer	4.62e-06	5.37e-05	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—IL6—stomach cancer	4.56e-06	5.31e-05	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—KRAS—stomach cancer	4.38e-06	5.1e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—PPP2R1A—stomach cancer	4.27e-06	4.97e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—GSTP1—stomach cancer	4.19e-06	4.88e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—HMOX1—stomach cancer	4.13e-06	4.81e-05	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—PIK3CA—stomach cancer	4.03e-06	4.68e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—TYMS—stomach cancer	3.9e-06	4.53e-05	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—TP53—stomach cancer	3.89e-06	4.53e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—GSTM1—stomach cancer	3.85e-06	4.48e-05	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—HRAS—stomach cancer	3.72e-06	4.33e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—ERCC2—stomach cancer	3.62e-06	4.21e-05	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—IL6—stomach cancer	3.57e-06	4.15e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—MTHFR—stomach cancer	3.4e-06	3.96e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—CAV1—stomach cancer	3.14e-06	3.65e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—APOA1—stomach cancer	3.13e-06	3.65e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	3e-06	3.49e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—PPARG—stomach cancer	2.76e-06	3.21e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—ALB—stomach cancer	2.48e-06	2.89e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—NOS3—stomach cancer	2.37e-06	2.76e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—PTGS2—stomach cancer	2.17e-06	2.53e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—PIK3CA—stomach cancer	1.34e-06	1.55e-05	CbGpPWpGaD
